Steven J. Quinlan net worth and biography

Steven Quinlan Biography and Net Worth

CFO of Neogen

Steve has served as NEOGEN’s Chief Financial Officer since 2011, following nine previous years of CFO experience at Detrex Corporation, and 19 total years there. He’s responsible for our internal and external financial reporting, and manages our corporate accounting, treasury, human resources, IT and investor relations groups. He began his career in 1985 on the audit staff at Price Waterhouse (now PWC).

What is Steven J. Quinlan's net worth?: The estimated net worth of Steven J. Quinlan is at least $450,581.94 as of October 11th, 2022. Mr. Quinlan owns 32,722 shares of Neogen stock worth more than $450,582 as of December 3rd. This net worth approximation does not reflect any other investments that Mr. Quinlan may own. Learn More about Steven J. Quinlan's net worth.
How do I contact Steven J. Quinlan?: The corporate mailing address for Mr. Quinlan and other Neogen executives is 620 LESHER PLACE, LANSING MI, 48912. Neogen can also be reached via phone at (517) 372-9200 and via email at [email protected]. Learn More on Steven J. Quinlan's contact information.
Has Steven J. Quinlan been buying or selling shares of Neogen?: Steven J. Quinlan has not been actively trading shares of Neogen over the course of the past ninety days. Most recently, on Tuesday, October 11th, Steven J. Quinlan bought 5,000 shares of Neogen stock. The stock was acquired at an average cost of $11.63 per share, with a total value of $58,150.00. Following the completion of the transaction, the chief financial officer now directly owns 32,722 shares of the company's stock, valued at $380,556.86. Learn More on Steven J. Quinlan's trading history.
Who are Neogen's active insiders?: Neogen's insider roster includes John Adent (President, CEO & Director), William Boehm (Director), James Borel (Director), Ronald Green (Director), Douglas Jones (Insider), Jason Lilly (VP), Terri Morrical (Director), David Naemura (CFO), G. Papesh (Director), Steven Quinlan (CFO), James Tobin (Director), and Darci Vetter (Director). Learn More on Neogen's active insiders.
Are insiders buying or selling shares of Neogen?: In the last twelve months, Neogen insiders bought shares 6 times. They purchased a total of 70,500 shares worth more than $912,885.00. The most recent insider tranaction occured on October, 11th when CEO John Edward Adent bought 14,500 shares worth more than $200,100.00. Insiders at Neogen own 1.1% of the company. Learn More about insider trades at Neogen.
Information on this page was last updated on 10/11/2024.

Steven J. Quinlan Insider Trading History at Neogen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/11/2022	Buy	5,000	$11.63	$58,150.00	32,722
9/29/2021	Sell	5,700	$44.05	$251,085.00
4/14/2021	Sell	13,001	$93.93	$1,221,183.93	26,471
1/7/2021	Sell	9,333	$84.49	$788,545.17	22,803
1/14/2020	Sell	8,031	$69.65	$559,359.15	21,501
10/15/2019	Sell	4,801	$65.00	$312,065.00	18,271
7/25/2019	Sell	15,000	$69.04	$1,035,600.00	28,470
5/1/2019	Sell	6,902	$60.13	$415,017.26	20,372
2/19/2019	Sell	4,800	$62.50	$300,000.00
8/30/2018	Sell	3,600	$89.08	$320,688.00	17,070
7/23/2018	Sell	3,802	$82.01	$311,802.02	17,272
5/7/2018	Sell	5,000	$71.82	$359,100.00	18,470
3/27/2018	Sell	5,000	$66.13	$330,650.00	15,203
2/21/2018	Sell	2,000	$60.15	$120,300.00	15,470
10/31/2017	Sell	4,000	$80.26	$321,040.00	14,103
10/4/2017	Sell	2,250	$78.52	$176,670.00
9/25/2017	Sell	2,772	$73.54	$203,852.88	12,875
8/8/2017	Sell	4,000	$68.68	$274,720.00	14,103
4/27/2017	Sell	2,676	$63.68	$170,407.68	12,779
1/4/2017	Sell	5,352	$66.13	$353,927.76	15,455
11/14/2016	Sell	3,000	$61.28	$183,840.00	13,103
9/30/2016	Sell	3,000	$55.15	$165,450.00	13,103
3/24/2016	Buy	2,236	$44.73	$100,016.28	10,103
9/22/2015	Buy	1,060	$47.17	$50,000.20	7,867
7/22/2015	Sell	4,500	$59.76	$268,920.00
2/19/2015	Sell	1,500	$48.70	$73,050.00

Steven J. Quinlan Buying and Selling Activity at Neogen

Neogen Company Overview

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Today's Range

Now: $12.96

$12.84

$13.76

50 Day Range

MA: $14.89

$13.58

$16.95

2 Week Range

Now: $12.96

$11.46

$20.89

Volume

776,415 shs

Average Volume

1,894,245 shs

Market Capitalization

$2.81 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Media Is Mocking Elon, But Wait Until They See This Demo

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.